The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases

Metformin can suppress gluconeogenesis and reduce blood sugar by activating adenosine monophosphate-activated protein kinase (AMPK) and inducing small heterodimer partner (SHP) expression in the liver cells. The main mechanism of metformin’s action is related to its activation of the AMPK enzyme and...

Descripción completa

Detalles Bibliográficos
Autor principal: Hasanvand, Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007580/
https://www.ncbi.nlm.nih.gov/pubmed/35419709
http://dx.doi.org/10.1007/s10787-022-00980-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007580/
https://www.ncbi.nlm.nih.gov/pubmed/35419709
http://dx.doi.org/10.1007/s10787-022-00980-6

Ejemplares similares